Anti-Cancer Agents in Medicinal Chemistry
Title:Meet Our Associate Editor
Volume: 18 Issue: 8
Author(s): Hai-Liang Zhu
Affiliation:
Export Options
About this article
Cite this article as:
Zhu Hai-Liang , Meet Our Associate Editor, Anti-Cancer Agents in Medicinal Chemistry 2018; 18 (8) . https://dx.doi.org/10.2174/187152061808181112124329
DOI https://dx.doi.org/10.2174/187152061808181112124329 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
21
2
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Direct and Indirect Antimicrobial Activities of Neuropeptides and their Therapeutic Potential
Current Protein & Peptide Science Quality, Safety and Efficacy in the ‘Off-Label’ Use of Medicines
Current Drug Safety Meet Our Editorial Board Member
Mini-Reviews in Medicinal Chemistry Biological Activity Evaluation of Novel 1,2,4-Triazine Derivatives Containing Thiazole/Benzothiazole Rings
Anti-Cancer Agents in Medicinal Chemistry Natural and Synthetic Iminosugars as Carbohydrate Processing Enzyme Inhibitors for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Drug Eluting Stents and Beyond
Current Pharmaceutical Design Improving DNA Vaccine Performance Through Vector Design
Current Gene Therapy Pharmacological Inhibition of the Bcl-2 Family of Apoptosis Regulators as Cancer Therapy
Current Molecular Pharmacology Pharmacogenetic Aspects of Drug Metabolizing Enzymes in Busulfan Based Conditioning Prior to Allogenic Hematopoietic Stem Cell Transplantation in Children
Current Drug Metabolism Editorial [Hot Topic: Gene Therapy for Cancer (Guest Editor: Maria G. Castro)]
Current Gene Therapy Editorial (Thematic Issue: “Dietary Polyphenols: Well beyond the Antioxidant Capacity”)
Current Pharmaceutical Biotechnology Serum Tumor Markers in Stage I-II Breast Cancer
Medicinal Chemistry Design and Synthesis of New Selective P-gp Substrates and Inhibitors
Current Pharmaceutical Design Promises of Nanotechnology for Drug Delivery to Brain in Neurodegenerative Diseases
Current Nanoscience Novel Targeted Therapies and Combinations for the Treatment of Multiple Myeloma
Cardiovascular & Hematological Disorders-Drug Targets Redox-Active Quinones and Ascorbate: An Innovative Cancer Therapy That Exploits the Vulnerability of Cancer Cells to Oxidative Stress
Anti-Cancer Agents in Medicinal Chemistry Muscarinic Receptors as Targets for Metronomic Therapy in Breast Cancer
Current Pharmaceutical Design Interaction of Endocannabinoid Receptors with Biological Membranes
Current Medicinal Chemistry Novel [1,2,4] Triazol [4,3-a] Pyridine Derivatives as Potential Selective c-Met Inhibitors with Improved Pharmacokinetic Properties
Anti-Cancer Agents in Medicinal Chemistry EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors
Current Cancer Drug Targets